Plasmid-mediated quinolone resistance (PMQR) and mutations in the topoisomerase genes of Salmonella enterica strains from Brazil.

Rafaela Ferrari, Antonio Galiana, Rosa Cremades, Juan Carlos Rodríguez, Marciane Magnani, M C B Tognim, Tereza C R M Oliveira, Gloria Royo
Author Information
  1. Rafaela Ferrari: Departamento de Ciência e Tecnologia de Alimentos, Centro de Ciências Agrárias, Universidade Estadual de Londrina, Londrina, PR, Brazil.

Abstract

The objective of this study was to identify mutations in the Quinolone Resistance Determining sources Regions (QRDR) of the gyrA, gyrB, parC, and parE genes and to determine if any of the qnr variants or the aac(6')-Ib-cr variant were present in strains of Salmonella spp. isolated in Brazil. A total of 126 Salmonella spp. strains from epidemic (n = 114) and poultry (n = 12) origin were evaluated. One hundred and twelve strains (88.8%) were resistant to nalidixic acid (NAL) and 29 (23.01%) showed a reduced susceptibility to ciprofloxacin (Cip). The mutations identified were substitutions limited to the QRDR of the gyrA gene in the codons for Serine 83, Aspartate 87 and Alanine 131. The sensitivity to NAL seems to be a good phenotypic indication of distinguishing mutated and non-mutated strains in the QRDR, however the double mutation in gyrA did not cause resistance to ciprofloxacin. The qnrA1 and qnrB19 genes were detected, respectively, in one epidemic strain of S. Enteritidis and one strain of S. Corvallis of poultry origin. Despite previous detection of qnr genes in Brazil, this is the first report of qnr gene detection in Salmonella, and also the first detection of qnrB19 gene in this country. The results alert for the continuous monitoring of Quinolone resistance determinants in order to minimize the emergence and selection of Salmonella spp. strains showing reduced susceptibility or resistance to quinolones.

Keywords

References

  1. Indian J Biochem Biophys. 2009 Apr;46(2):147-53 [PMID: 19517991]
  2. Jpn J Infect Dis. 2006 Apr;59(2):117-9 [PMID: 16632912]
  3. Microbes Infect. 2006 Jun;8(7):1937-44 [PMID: 16714137]
  4. J Antimicrob Chemother. 2009 May;63(5):909-16 [PMID: 19270312]
  5. J Antimicrob Chemother. 2008 Sep;62(3):474-8 [PMID: 18552340]
  6. Antimicrob Agents Chemother. 2003 Nov;47(11):3567-73 [PMID: 14576119]
  7. Antimicrob Agents Chemother. 2003 Feb;47(2):559-62 [PMID: 12543659]
  8. Clin Infect Dis. 2003 Jul 1;37(1):75-81 [PMID: 12830411]
  9. Antimicrob Agents Chemother. 2007 Apr;51(4):1527-9 [PMID: 17220425]
  10. J Clin Microbiol. 2009 Sep;47(9):2751-8 [PMID: 19571019]
  11. Emerg Infect Dis. 2008 Jul;14(7):1129-31 [PMID: 18598639]
  12. Antimicrob Agents Chemother. 1999 Sep;43(9):2131-7 [PMID: 10471553]
  13. J Med Microbiol. 2007 Jan;56(Pt 1):136-137 [PMID: 17172529]
  14. Diagn Microbiol Infect Dis. 2010 May;67(1):110-3 [PMID: 20227223]
  15. Diagn Microbiol Infect Dis. 2010 May;67(1):70-7 [PMID: 20227228]
  16. Antimicrob Agents Chemother. 2005 Jul;49(7):3050-2 [PMID: 15980397]
  17. FEMS Microbiol Rev. 2002 Mar;26(1):3-16 [PMID: 12007640]
  18. J Antimicrob Chemother. 1998 Jun;41(6):635-41 [PMID: 9687102]
  19. J Antimicrob Chemother. 2003 May;51(5):1287-91 [PMID: 12668577]
  20. Vet Microbiol. 2005 Apr 10;106(3-4):297-301 [PMID: 15778037]
  21. Braz J Microbiol. 2010 Apr;41(2):497-500 [PMID: 24031522]
  22. Epidemiol Infect. 2009 Jun;137(6):871-8 [PMID: 18687156]
  23. J Antimicrob Chemother. 2007 Sep;60(3):704-6 [PMID: 17635876]
  24. Antimicrob Agents Chemother. 2006 Aug;50(8):2872-4 [PMID: 16870791]
  25. J Antimicrob Chemother. 2009 Feb;63(2):274-81 [PMID: 19001452]
  26. Lancet Infect Dis. 2006 Oct;6(10):629-40 [PMID: 17008172]
  27. Antimicrob Agents Chemother. 2003 Feb;47(2):827-9 [PMID: 12543704]
  28. Antimicrob Agents Chemother. 2009 May;53(5):1892-7 [PMID: 19258263]
  29. Antimicrob Agents Chemother. 1998 Oct;42(10):2661-7 [PMID: 9756773]
  30. Emerg Infect Dis. 2010 Nov;16(11):1789-91 [PMID: 21029547]
  31. Antimicrob Agents Chemother. 2009 Sep;53(9):3832-6 [PMID: 19596880]
  32. Antimicrob Agents Chemother. 2009 Apr;53(4):1665-6 [PMID: 19164145]
  33. Int J Antimicrob Agents. 2005 May;25(5):358-73 [PMID: 15848289]
  34. Antimicrob Agents Chemother. 2004 Apr;48(4):1145-50 [PMID: 15047514]
  35. Clin Infect Dis. 2006 Aug 1;43(3):297-304 [PMID: 16804843]
  36. J Antimicrob Chemother. 2007 Apr;59(4):751-4 [PMID: 17307773]
  37. Int J Antimicrob Agents. 2005 Jun;25(6):453-63 [PMID: 15890498]
  38. Antimicrob Agents Chemother. 1998 Jul;42(7):1850-2 [PMID: 9661034]
  39. Int J Antimicrob Agents. 2010 May;35(5):482-5 [PMID: 20188522]
  40. Antimicrob Agents Chemother. 2002 Aug;46(8):2582-7 [PMID: 12121936]
  41. J Antimicrob Chemother. 2009 Jan;63(1):87-94 [PMID: 18984647]
  42. Antimicrob Agents Chemother. 2001 Aug;45(8):2378-80 [PMID: 11451702]

MeSH Term

Animals
Anti-Bacterial Agents
Brazil
DNA Topoisomerases
Drug Resistance, Bacterial
Humans
Microbial Sensitivity Tests
Mutation
Poultry
Quinolones
Salmonella Infections
Salmonella Infections, Animal
Salmonella enterica

Chemicals

Anti-Bacterial Agents
Quinolones
DNA Topoisomerases

Word Cloud

Created with Highcharts 10.0.0strainsSalmonellaQRDRgenesresistancemutationsgyrAqnrsppBrazilciprofloxacingenedetectionquinoloneepidemicn=poultryoriginNALreducedsusceptibilitymutationqnrB19onestrainSfirstPMQRobjectivestudyidentifyQuinoloneResistanceDeterminingsourcesRegionsgyrBparCparEdeterminevariantsaac6'-Ib-crvariantpresentisolatedtotal12611412evaluatedOnehundredtwelve888%resistantnalidixicacid292301%showedCipidentifiedsubstitutionslimitedcodonsSerine83Aspartate87Alanine131sensitivityseemsgoodphenotypicindicationdistinguishingmutatednon-mutatedhoweverdoublecauseqnrA1detectedrespectivelyEnteritidisCorvallisDespitepreviousreportalsocountryresultsalertcontinuousmonitoringdeterminantsorderminimizeemergenceselectionshowingquinolonesPlasmid-mediatedtopoisomeraseenterica

Similar Articles

Cited By (21)